• Publication Slide

  • Deal of the Week 2


  • USA

  • welcome

  • slide_1

Quanta BioDesign

Quanta BioDesign is a research and manufacturing company committed to the development of a full range of discrete polyethylene glycol (dPEG®) PEGylation reagents for applications in diagnostics, therapeutics, peptide synthesis, oligonucleotide synthesis, and nanotechnology.

Quanta BioDesign’s vision incorporates a dedicated commitment to producing the most useful compounds for your current and future applications and needs using synthetic and process technology that allows the most economic incorporation of these products into your application.


IBC’s Bioconjugates: From Targets to Therapeutics

May 18 – 19, 2015
Booth # 214
Parc 55 Hilton
55 Cyril Magnin St
San Francisco, CA 94102

World ADC 2015

October 19 – 22, 2015
San Diego, CA